Joint Formulary & PAD

Obeticholic acid - Primary biliary cholangitis

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Tablets
Associated Icons :
BNF SPC
NHSE
NICE
R
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Obeticholic acid
Indication :
Primary biliary cholangitis
Group Name :
Keywords :
Biliary cirrhosis
Brand Names Include :
Ocalvia
Important Information :
Dose adjustment and monitoring in pre-existing moderate / severe hepatic impairment. NHSE specialised commissioning - RSFT only.
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Obeticholic acid is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Primary biliary cholangitis.

Committee Recommendations (1)

08 Nov 17 - Not Set

This drug falls under the responsibility of NHS England Specialised Commissioning and should therefore not be prescribed in Primary Care.
Treatment should remain with the specialist (RED) hospital only drug.

GPs should ensure that patient medication records include any medicine for which prescribing remains the responsibility of secondary or tertiary care. This will ensure that GP records, which are accessed by other healthcare providers, are a true and accurate reflection of the patient’s medication.